FIELD: medicine, virology, biotechnology. SUBSTANCE: method involves immunization of animal-producers with viral antigens prepared from organs of the infected animals (sheep, goats). Blood sampling in animal-producers is carried out at neutralization index 2.0 lg and above and 2.75 lg and above for viruses Marburg and Ebola, respectively. Globulin fractions were prepared from serum blood by alcohol precipitation at negative temperatures followed by globulin purification. The obtained preparation shows low reactivity, apyrogenic and does not induce immunostimulation and immunodepression. EFFECT: improved method of preparing, enhanced quality of immunoglobulins. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF HYPERIMMUNE SERUM CONTAINING HETEROLOGIC IMMUNOGLOBULINES AGAINST EBOLA FEVER | 2016 |
|
RU2627631C1 |
LIQUID PREPARATION CONTAINING IMMUNOGLOBULIN EFFICIENT AGAINST MARBURG FEVER FROM HORSE BLOOD SERUM (HORSE IMMUNOGLOBULIN MARBURG) | 2003 |
|
RU2257916C1 |
PREPARATION CONTAINING IMMUNOGLOBULIN AGAINST ABOL FEVER FROM HORSE BLOOD SERUM AND LIQUID ABOL IMMUNOGLOBULIN | 1996 |
|
RU2130318C1 |
METHOD OF PHYLOVIRUS SUSPENSION CULTURING IN CELL CULTURE ON MICROCARRIERS | 1993 |
|
RU2076905C1 |
METHOD FOR PRODUCING LIQUID IMMUNOGLOBULIN AGAINST EBOLA FEVER FROM HORSE BLOOD SERUM | 2017 |
|
RU2673546C1 |
METHOD OF OBTAINING PURIFIED HETEROLOGOUS IMMUNOGLOBULIN AGAINST EBOLA FEVER | 2023 |
|
RU2815252C1 |
PROCESS FOR MANUFACTURE OF CONCENTRATES OF VIRUSES THAT PROVOKE HEMORRHAGIC FEVER AND POSSESSING IMMUNOGENIC AND PROTECTIVE ACTIVITY | 1991 |
|
RU2029561C1 |
METHOD FOR PREPARING HIGHLY SPECIFIC HETEROLOGOUS ANTIRABIES SERUM | 2006 |
|
RU2322503C1 |
METHOD OF PREPARING SERA CONTAINING ANTIBODIES RAISED TO MARBURG VIRUS | 1995 |
|
RU2085214C1 |
RECOMBINANT PLASMID DNA PET21-NPVE CONTAINING NUCLEOLOPROTEIN (NP) GENE OF EBOLA VIRUS AND RECOMBINANT PROTEIN NP-VE, OBTAINED AS RESULT OF EXPRESSION OF NP GENE OF EBOLA VIRUS USING RECOMBINANT PLASMID DNA PET21-NPVE AND POSSESSING IMMUNOGENIC AND ANTIGENIC PROPERTIES | 2020 |
|
RU2739505C1 |
Authors
Dates
1997-09-10—Published
1992-04-01—Filed